In this study, the 57 genes involved in immune response and T-cell activation were decreased in patients with high VEGF expression in both ABC-like and GCB-like subtypes of DLBCL, indicating that drugs targeting immune response would be efficient in both subtypes. Here, VEGFA is linked to diffuse large B-cell lymphoma.